RIBOB: A study on the efficacy and safety of ribociclib in combination with letrozole in older women (≥70 years) with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (aBC) with no prior systemic therapy for advanced disease

Annals of Oncology ◽

10.1093/annonc/mdz242.080 ◽

2019 ◽

Vol 30 ◽

pp. v140

Author(s):

C. Kenis ◽

N.F. Ponde ◽

L. Decoster ◽

E. de Azambuja ◽

G. Jerusalem ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Older Women ◽

Systemic Therapy ◽

Hormone Receptor ◽

Advanced Disease ◽

Advanced Breast ◽

Efficacy And Safety ◽

Hormone Receptor Positive ◽

Prior Systemic Therapy

Download Full-text

Ribociclib + letrozole for postmenopausal women with hormone receptor-positive (HR+), HER2-negative advanced breast cancer (ABC) who received no prior therapy for advanced disease

Geburtshilfe und Frauenheilkunde ◽

10.1055/s-0036-1592812 ◽

2016 ◽

Vol 76 (10) ◽

Author(s):

EM Grischke ◽

A Nusch ◽

N Marschner ◽

W Abenhardt ◽

J Wilke ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Hormone Receptor ◽

Advanced Disease ◽

Advanced Breast ◽

Prior Therapy ◽

Hormone Receptor Positive

Download Full-text

The efficacy and safety of palbociclib combined with endocrine therapy in patients with hormone receptor-positive HER2-negative advanced breast cancer

Anti-Cancer Drugs ◽

10.1097/cad.0000000000001210 ◽

2021 ◽

Vol Publish Ahead of Print ◽

Author(s):

Linhui Zhang ◽

Guohong Song ◽

Bin Shao ◽

Ling Xu ◽

Yu Xiao ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Endocrine Therapy ◽

Hormone Receptor ◽

Advanced Breast ◽

Efficacy And Safety ◽

Hormone Receptor Positive

Download Full-text

Correction to: Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis

Breast Cancer Research and Treatment ◽

10.1007/s10549-018-5047-9 ◽

2018 ◽

Vol 173 (2) ◽

pp. 487-487

Author(s):

Jiayu Wang ◽

Binghe Xu ◽

Wenna Wang ◽

Xiaoyu Zhai ◽

Xuelian Chen

Keyword(s):

Breast Cancer ◽

Literature Review ◽

Advanced Breast Cancer ◽

Systematic Literature Review ◽

Hormone Receptor ◽

Meta Analysis ◽

Advanced Breast ◽

Efficacy And Safety ◽

Hormone Receptor Positive

Download Full-text

Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis

Breast Cancer Research and Treatment ◽

10.1007/s10549-018-4867-y ◽

2018 ◽

Vol 171 (3) ◽

pp. 535-544 ◽

Cited By ~ 5

Author(s):

Jiayu Wang ◽

Binghe Xu ◽

Wenna Wang ◽

Xiaoyu Zhai ◽

Xuelian Chen

Keyword(s):

Breast Cancer ◽

Literature Review ◽

Advanced Breast Cancer ◽

Systematic Literature Review ◽

Hormone Receptor ◽

Meta Analysis ◽

Advanced Breast ◽

Efficacy And Safety ◽

Hormone Receptor Positive

Download Full-text

Efficacy and safety of selective cyclin-dependent kinases 4/6 inhibitors in hormone-receptor-positive, HER2-negative advanced breast cancer – results from a real-world setting

Cancer Treatment and Research Communications ◽

10.1016/j.ctarc.2020.100201 ◽

2020 ◽

Vol 25 ◽

pp. 100201

Author(s):

ANJA KOVAČ ◽

Erika Matos ◽

Cvetka Grašič Kuhar ◽

Marina Čakš ◽

Tanja Ovčariček ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Real World ◽

Hormone Receptor ◽

Advanced Breast ◽

Efficacy And Safety ◽

Cyclin Dependent Kinases ◽

Hormone Receptor Positive ◽

Real World Setting

Download Full-text

Efficacy and Safety of Fulvestrant 500mg in Hormone-receptor Positive Human Epidermal Receptor 2 Negative Advanced Breast Cancer: A Real-world Study in China

Journal of Cancer ◽

10.7150/jca.47960 ◽

2020 ◽

Vol 11 (22) ◽

pp. 6612-6622 ◽

Cited By ~ 2

Author(s):

Wen Lei ◽

Huiping Li ◽

Guohong Song ◽

Ruyan Zhang ◽

Ran Ran ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Real World ◽

Hormone Receptor ◽

Advanced Breast ◽

Efficacy And Safety ◽

Hormone Receptor Positive ◽

Human Epidermal Receptor

Download Full-text

Efficacy and safety of everolimus (eve) and exemestane (exe) in postmenopausal hormone-receptor positive (hr+) advanced breast cancer (abc) patients (pts) beyond clinical trials: preliminary results of the observational multicenter eva study

Annals of Oncology ◽

10.1093/annonc/mdw337.32 ◽

2016 ◽

Vol 27 ◽

pp. iv69

Author(s):

V. Torri ◽

M.E. Cazzaniga ◽

F. Galli ◽

M.R. Valerio ◽

C. Ficorella ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trials ◽

Advanced Breast Cancer ◽

Hormone Receptor ◽

Advanced Breast ◽

Efficacy And Safety ◽

Postmenopausal Hormone ◽

Preliminary Results ◽

Hormone Receptor Positive

Download Full-text

Efficacy and safety of ribociclib (LEE011) + letrozole in elderly patients with hormone receptor-positive (HR+), HER2-negative (HER2−) advanced breast cancer (ABC) in MONALEESA-2

European Journal of Cancer ◽

10.1016/s0959-8049(17)30091-6 ◽

2017 ◽

Vol 72 ◽

pp. S1-S2 ◽

Cited By ~ 1

Author(s):

G.S. Sonke ◽

L.L. Hart ◽

M. Campone ◽

F. Erdkamp ◽

W. Janni ◽

...

Keyword(s):

Breast Cancer ◽

Elderly Patients ◽

Advanced Breast Cancer ◽

Hormone Receptor ◽

Advanced Breast ◽

Efficacy And Safety ◽

Hormone Receptor Positive

Download Full-text

PALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast cancer

Contemporary Clinical Trials Communications ◽

10.1016/j.conctc.2018.05.012 ◽

2018 ◽

Vol 10 ◽

pp. 190-192

Author(s):

Filipa Lynce ◽

Mervat Saleh ◽

Ayesha Shajahan-Haq ◽

Christopher Gallagher ◽

Asma Dilawari ◽

...

Keyword(s):

Breast Cancer ◽

African American ◽

Advanced Breast Cancer ◽

African American Women ◽

Phase Ii ◽

Hormone Receptor ◽

Advanced Breast ◽

Safety Study ◽

American Women ◽

Hormone Receptor Positive

Download Full-text

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2

Annals of Oncology ◽

10.1093/annonc/mdu009 ◽

2014 ◽

Vol 25 (4) ◽

pp. 808-815 ◽

Cited By ~ 87

Author(s):

H.S. Rugo ◽

K.I. Pritchard ◽

M. Gnant ◽

S. Noguchi ◽

M. Piccart ◽

...

Keyword(s):

Breast Cancer ◽

Adverse Events ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Hormone Receptor ◽

Time Course ◽

Advanced Breast ◽

Hormone Receptor Positive

Download Full-text